Activation of autophagy by rapamycin and its derivatives, via inhibition of mTOR, has shown benefits in cell and animal models as treatments for neurodegenerative diseases (35), however, mTOR inhibition also leads to decreased protein synthesis; furthermore, side effects of rapamycin in humans limit its use, especially over the long term. Here, MTOR is linked to neurodegenerative disease.